EMVision Medical Devices Prepares Study to Support Remote Use of emu Bedside Brain Scanner
EMV: Revenue up 57%, net loss down 15%, strong clinical progress and cash position maintained
EMVision Making Strong Progress with emu and First Responder Brain Scanners
EMVision Secures Nature-Portfolio Validation for AI Stroke Scanner
EMVision Medical Devices De-Risks Rural Stroke Use Cases with Aeromedical Study
Bell Potter Reaffirms Their Buy Rating on EMvision Medical Devices Ltd. (EMV)